Abstract
Human blood has been transfused for about 60-70 years. Over this time, the practice of blood transfusion has changed dramatically. One major change is the separation of blood into its various components. As a result, the patient can receive only the blood component in which he is deficient. In this way, the risk of side effects—particularly hepatitis—is lessened. This article briefly reviews the various blood products, the indications for their use, and some associated risks. These products include oxygen-carrying products, plasma products, blood products used to correct hemostatic defects, and immune globulin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blajchman M. A., Herst R., Perrault R. A. Blood component therapy in anaesthetic practice. Can Anaesth Soc J. 1983 Jul;30(4):382–389. doi: 10.1007/BF03007861. [DOI] [PubMed] [Google Scholar]
- Geyer R. P. Oxygen transport in vivo by means of perfluorochemical preparations. N Engl J Med. 1982 Jul 29;307(5):304–305. doi: 10.1056/NEJM198207293070509. [DOI] [PubMed] [Google Scholar]